WorenineCAS# 38763-29-0 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 38763-29-0 | SDF | Download SDF |
| PubChem ID | 20055073 | Appearance | Cryst. |
| Formula | C20H16NO4+ | M.Wt | 334.11 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC1=C2C3=CC4=C(C=C3CC[N+]2=CC5=CC6=C(C=C15)OCO6)OCO4 | ||
| Standard InChIKey | LCXREBMNASQAOC-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C20H16NO4/c1-11-14-6-18-17(23-10-24-18)5-13(14)8-21-3-2-12-4-16-19(25-9-22-16)7-15(12)20(11)21/h4-8H,2-3,9-10H2,1H3/q+1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Worenine Dilution Calculator
Worenine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.993 mL | 14.9651 mL | 29.9303 mL | 59.8605 mL | 74.8257 mL |
| 5 mM | 0.5986 mL | 2.993 mL | 5.9861 mL | 11.9721 mL | 14.9651 mL |
| 10 mM | 0.2993 mL | 1.4965 mL | 2.993 mL | 5.9861 mL | 7.4826 mL |
| 50 mM | 0.0599 mL | 0.2993 mL | 0.5986 mL | 1.1972 mL | 1.4965 mL |
| 100 mM | 0.0299 mL | 0.1497 mL | 0.2993 mL | 0.5986 mL | 0.7483 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Triptolide
Catalog No.:BCN5984
CAS No.:38748-32-2
- 3-Epibetulinic acid
Catalog No.:BCN8531
CAS No.:38736-77-5
- Seneciphylline N-oxide
Catalog No.:BCN5439
CAS No.:38710-26-8
- Preskimmianine
Catalog No.:BCN6667
CAS No.:38695-41-9
- Groenlandicine
Catalog No.:BCN8189
CAS No.:38691-95-1
- DAPK Substrate Peptide
Catalog No.:BCC2400
CAS No.:386769-53-5
- Desvenlafaxine Succinate
Catalog No.:BCC5048
CAS No.:386750-22-7
- Neodiosmin
Catalog No.:BCN8337
CAS No.:38665-01-9
- Triptonide
Catalog No.:BCN5924
CAS No.:38647-11-9
- Tripdiolide
Catalog No.:BCN5985
CAS No.:38647-10-8
- Benzoylpaeoniflorin
Catalog No.:BCN6293
CAS No.:38642-49-8
- Lasiodonin
Catalog No.:BCN7156
CAS No.:38602-52-7
- Swazine
Catalog No.:BCN2143
CAS No.:38763-74-5
- Cucurbitacin D
Catalog No.:BCN2355
CAS No.:3877-86-9
- Tetrahydroisocucurbitacin I
Catalog No.:BCN7874
CAS No.:3877-89-2
- Muristerone A
Catalog No.:BCC2397
CAS No.:38778-30-2
- Tectoruside
Catalog No.:BCN8262
CAS No.:38784-73-5
- Tandutinib (MLN518)
Catalog No.:BCC4499
CAS No.:387867-13-2
- Lapatinib Ditosylate
Catalog No.:BCC2083
CAS No.:388082-78-8
- Emodin-1-O-glucoside
Catalog No.:BCN8512
CAS No.:38840-23-2
- Tetrahydroepiberberine
Catalog No.:BCN2649
CAS No.:38853-67-7
- PSN 375963 hydrochloride
Catalog No.:BCC7663
CAS No.:388575-52-8
- CK 869
Catalog No.:BCC6347
CAS No.:388592-44-7
- Z-Glu(OtBu)-OH
Catalog No.:BCC2776
CAS No.:3886-08-6
Characterization of metabolites of worenine in rat biological samples using liquid chromatography-tandem mass spectrometry.[Pubmed:19773142]
J Pharm Biomed Anal. 2010 Jan 5;51(1):236-43.
The in vivo and in vitro metabolites of Worenine in rat were identified or characterized using a specific and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. In vivo samples including rat urine, feces, and plasma samples were collected after ingestion of 25 mg/kg Worenine to healthy rats. The in vivo and in vitro samples were cleaned up by a solid-phase extraction procedure (C18 cartridges) and a liquid-liquid extraction procedure, respectively. Then these pretreated samples were injected into a reversed-phase C18 column with mobile phase of methanol-ammonium acetate (2mM, adjusted to pH 3.5 with formic acid) (60:40, v/v) and detected by an on-line MS/MS system. As a result, at least twenty-seven metabolites and the parent medicine were found in rat urine after ingestion of Worenine. Seven metabolites and the parent medicine were identified or characterized in rat feces. Three metabolites and the parent medicine were detected in rat plasma. One metabolite was found in the rat intestinal flora incubation mixture, and three metabolites were characterized in the homogenized liver incubation mixture. The main phase I metabolism of Worenine in rat was dehydrogenization, hydrogenation, hydroxylation, and demethylene reactions, and that of phase II was sulfation and glucuronidation.
